Image

Efficacy and Safety of Sivelestat Sodium and Dexamethasone in the Treatment of ARDS

Recruiting
18 years of age
Both
Phase N/A

Powered by AI

Overview

The goal of this clinical trial is to evaluate the efficacy and safety of Sivelestat sodium and dexamethasone in the treatment of patients with moderate to severe ARDS. The main questions it aims to answer are:

  • Is Sivelestat sodium more effective in the treatment of patients with moderate to severe ARDS compared with placebo?
  • Is dexamethasone more effective in the treatment of patients with moderate to severe ARDS compared with placebo? Participants will receive Sivelestat sodium, dexamethasone or placebo. Researchers will compare the efficacy and safety of Sivelestat sodium, dexamethasone and placebo.

Eligibility

Inclusion Criteria:

  • Patients with moderate-to-severe ARDS in the acute exacerbation phase who meet the diagnostic criteria for moderate-to-severe ARDS
  • Receiving tracheal intubation for mechanical ventilation within 72 hours after an episode of moderate-to-severe ARDS
  • ARDS onset to randomized grouping within 72 hours (starting at the time of onset documented in the medical record)
  • Patient volunteers to participate in the study and signs an informed consent form

Exclusion Criteria:

  • Pregnancy or breastfeeding
  • brain death
  • Advanced cancer or other terminal disease
  • History of allergy to Sivelestat Sodium and Dexamethasone
  • Severe chronic obstructive pulmonary disease
  • History of severe cardiovascular disease, such as heart failure, uncontrolled coronary artery disease, cardiomyopathy, uncontrolled cardiac arrhythmia, uncontrolled hypertension, or history of heart or cerebral infarction within the past six months
  • Organ transplant or allogeneic stem cell transplant recipients
  • Fatal active fungal infections
  • neuromuscular disease that affects voluntary breathing
  • Genetic or acquired severe immunodeficiencies such as human immunodeficiency virus (HIV) infection, chronic granulomatous disease, severe combined immunodeficiencies
  • Patients and/or legal representatives who sign a Do Not Resuscitate (DNR) advance directive, or who abandon treatment
  • Participating in other clinical trials

Study details

Acute Respiratory Distress Syndrome

NCT06387823

Peking Union Medical College Hospital

11 June 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.